Evaluation of the Quality and Reliability of Youtube Videos on Neurological Symptoms of COVID-19

Amaç: Şizofreni tanılı hastalarda klozapin ile eşzamanlı olarak uygulanan elektrokonvulziv tedavinin daha iyi tedavi yanıtı ve hastanede yatış süresinde kısalmaya neden olma olasılığını incelemek amaçlanmıştır. Yöntemler: Kadın psikiyatri servisimizde 5 yıl boyunca (01.02.2014 ve 01.02.2019 arasında) yatarak tedavi gören şizofreni tanılı hastaların tıbbi kayıtları retrospektif olarak incelendi. Tedavi yanıtını değerlendirmede Klinik Global İzlem – İyileşme (KGİ-İ) ölçeği kullanılmıştı. Bulgular: EKT ile tedavi edilmiş olan 191 olgu içinde; 8 şizofreni olgusu (K-EKT) EKT ve eşzamanlı klozapin ile tedavi edilmiş ve 14 olguya ise (EKT-Ö) önce EKT uygulanmış, sonrasında klozapin tedavisine başlanmıştı. İki grup arasında EKT seans sayıları ve nöbet süreleri açısından anlamlı fark yoktu (p > 0,05). EKT’ ye yanıt oranının (KGİ-İ: 2 ya da 3), K-EKT grubunda %75 (n=6); EKT-Ö grubunda ise %85,7 (n=12) olduğu görüldü. Ortalama KGİ-İ skorları arasında gruplar arasında anlamlı fark yoktu (p > 0,05). K-EKT grubunun hastanede yatış süresi (37,7  14,44 gün), EKT-Ö grubundan (56,0  19,2 gün) daha kısaydı (p = 0,04). EKT seansları sırasında ya da yatışlar süresince ciddi yan etki görülmedi. Sonuç: Her iki uygulamada da tedaviye iyi yanıt yüksek orandaydı ve anlamlı fark yoktu. EKT ile eşzamanlı klozapin uygulamasının hastanede yatış süresini anlamlı oranda kısaltırken ciddi bir komplikasyona ve yan etki artışına neden olmadığı görüldü.

Anahtar Kelimeler:

EKT, Şizofreni, Klozapin

Evaluation of the Quality and Reliability of Youtube Videos on Neurological Symptoms of COVID-19

Purpose: Determining whether adjunctive electroconvulsive therapy (ECT) with clozapine leads to better treatment response and fewer days in hospital for patients with schizophrenia. Methods: Medical records of patients with schizophrenia who were treated with ECT-clozapine combination in our women’s mental health clinic in a period of 5 years (between 01.02.2014 and 01.02.2019) were investigated retrospectively. Clinical Global Impression of Improvement (CGI-I) scale was used for assessing treatment response. Results: Of the 191 cases treated with ECT, there were 8 cases of schizophrenia who were treated with ECT and concomitant clozapine (C-ECT) and 14 cases who were treated with ECT before the initiation of clozapine (ECT-B). Number of ECT sessions and duration of seizures were not significantly different for both groups (p > 0.05). There was good and mild response (CGI-I score of 2 and 3) in 75% of the patients (n=6) for C-ECT and 85.7% of the patients (n=12) for ECT-B. Mean CGI-I scores between the two groups were not significantly different (p > 0.05). Duration of hospitalization for the C-ECT group (37.7  14.44 days) was shorter than the duration of hospitalization for the ECT-B group (56.0  19.2 days) (p = 0.04). No serious adverse events were observed during the ECT sessions or during the index hospitalizations Conclusion: Response rate was high and similar with both of the procedures and the duration of hospitalization was shorter for C-ECT group with no major complication and no significant increase in adverse effects.

Keywords:

ECT, Schizophrenia, Clozapine,

___

1. AlGhamdi KM, Moussa NA. Internet use by the public to search for health-related information. Int J Med Inform. 2012; 81:6. doi:10.1016/j.ijmedinf.2011.12.004
2. Fox S, Duggan M. Health online 2013, 2013. https://www.pewresearch. org/internet/2013/01/15/health-online-2013/. Accessed May 2, 2021.
3. YouTube. YouTube statistic page. https://www.omnicoreagency.com/ youtube-statistics/. Accessed April 25, 2021.
4. Powell J, Inglis N, Ronnie J, et al. The characteristics and motivations of online health information seekers: cross-sectional survey and qualitative interview study. J Med Internet Res. 2011; 13:e20. doi:10.2196/jmir.1600.
5. Atkinson NL, Saperstein SL, Pleis J. Using the internet for healthrelated activities: findings from a national probability sample. J Med Internet Res. 2009; 11:e-4. doi:10.2196/jmir.1035.
6. Bora K, Das D, Barman B, et al. Are Internet videos useful sources of information during global public health emergencies? A case study of YouTube videos during the 2015-16 Zika virus pandemic. Pathog Glob Health. 2018; 112:320–8. doi:10.1080/20477724.2018.1507784.
7. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020; 25:278–80. doi:10.1111/tmi.13383.
8. World Health Organization. Situation report Weekly Operational Update on COVID-19, 13 November 2020. https://www.who.int/publications/m/item/ weekly-operational-update-on-covid-19---13-november-2020
9. Wang D, Hu B, Hu C, et al.Clinical characteristics of 138 hospitalized patients with 2019 novel corona virus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–9. doi:10.1001/ jama.2020.1585.
10. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with corona virus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77:1–9. doi:10.1001/jamaneurol.2020.1127.
11. Gokcen HB, Gumussuyu G. A quality analysis of disc herniation videos on YouTube. World Neurosurg. 2019; 124:e799-e804. doi:10.1016/j.wneu.2019.01.146.
12. Charnock D, Shepperd S, Needham G, et al. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health.1999; 53:105- 11. doi:10.1136/jech.53.2.105.
13. Silberg WM, Lundberg GD, Musacchio RA. Assessing, controlling and assuring the quality of medical information on the Internet: Caveantlector et view or e Let the reader and viewer beware. JAMA. 1997; 277:1244-5. doi:10.1001/jama.1997.03540390074039
14. Kuru T, Eken H. Evaluation of the Quality and Reliability of YouTube Videos on Rotator Cuff Tears. Cureus. 2020; 12(2):e6852. doi:10.7759/cureus.6852.
15. Sankowski R, Mader S, Valdés-Ferrer SI. Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci. 2015; 9:28. doi:10.3389/fncel.2015.00028.
16. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020; 382:2268-70. doi:10.1056/NEJMc2008597.
17. Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69(6):1002– 9. doi:10.1136/gutjnl-2020-320926.
18. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, et al. Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med. 2020; 9(4):E941. doi:10.3390/ jcm9040941.
19. Conti P, D’Ovidio C, Conti C, et al. Progression in migraine: role of mast cells and pro-inflammatory and anti-inflammatory cytokines. Eur J Pharmacol. 2019; 844:87–94. doi:10.1016/j.ejphar.2018.12.004.
20. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mildto-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251–61. doi:10.1007/s00405-020-05965-1.
21. Fat MJL, Doja A, Barrowman N, et al. YouTube videos as a teaching tool and patient resource for infantile spasms. J Child Neurol. 2011; 26:804-9. doi:10.1177/0883073811402345.
22. Krishnan V, Leung LY, Caplan LR. A neurologist’s approach to delirium: diagnosis and management of toxic metabolic encephalopathies. Eur J Intern Med. 2014; 25(2):112–6. doi:10.1016/j.ejim.2013.11.010.
23. Lu L, Xiong W, Liu D, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia. 2020; 61(6):e49-e53. doi:10.1111/epi.16524.
24. Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology. 2020; 5:3000431. doi:10.1136/ svn-2020-000431.
25. Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382:2574-6. doi:10.1056/NEJMc2009191.
26. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020; 76:233-5. doi:10.1016/j.jocn.2020.04.062.
27. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020; 95(5):e601-5. doi:10.1212/WNL.0000000000009619.
28. Ahmed S, Leurent B, Sampson EL. Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis. Age Ageing. 2014; 43(3):326–33. doi:10.1093/ageing/afu022.
29. Haymes AT, Harries V. ‘How to stop a nose bleed’: an assessment of the quality of epistaxis treatment advice on YouTube. J Laryngol Otol. 2016; 130:749-54. doi:10.1017/S0022215116008410.